alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 07-6855 

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

 JACKIE MCKUBBIN, a/k/a Jack,

Defendant - Appellant.

Appeal from the United States District Court for the Western

District of North Carolina, at Charlotte. Richard L. Voorhees,

District Judge. (3:95-cr-00005-3)

Submitted: July 20, 2007 Decided: August 23, 2007

Before MICHAEL and KING, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Dismissed by unpublished per curiam opinion.

Jackie McKubbin, Appellant Pro Se. Amy Elizabeth Ray, OFFICE OF

THE UNITED STATES ATTORNEY, Asheville, North Carolina, for

Appellee.

Unpublished opinions are not binding precedent in this circuit.
*For the purpose of this appeal, we assume that the date

appearing on the notice of appeal is the earliest date it could

have been properly delivered to prison officials for mailing to the

court. Fed. R. App. P. 4(c); Houston v. Lack, 487 U.S. 266 (1988).

- 2 -

PER CURIAM:

Jackie McKubbin seeks to appeal nunc pro tunc his

conviction and life sentence imposed following his guilty plea to

a drug conspiracy and a firearms charge. In criminal cases, the

defendant must file the notice of appeal within ten days after the

entry of judgment. Fed. R. App. P. 4(b)(1)(A). With or without a

motion, upon a showing of excusable neglect or good cause, the

district court may grant an extension of up to thirty days to file

a notice of appeal. Fed. R. App. P. 4(b)(4); United States v.

Reyes, 759 F.2d 351, 353 (4th Cir. 1985).

The district court entered an amended judgment on

September 15, 1999. The notice of appeal was filed on May 31,

2007.* Because McKubbin failed to file a timely notice of appeal

or to obtain an extension of the appeal period, we dismiss the

appeal for lack of jurisdiction. We deny McKubbin’s motions to

rescind the informal briefing order, for appointment of counsel,

and for reconsideration of the order deferring action on the motion

for appointment of counsel. We dispense with oral argument because

the facts and legal contentions are adequately presented in the
- 3 -

materials before the court and argument would not aid the

decisional process.

DISMISSED
[Federal Register Volume 60, Number 74 (Tuesday, April 18, 1995)]
[Notices]
[Page 19397]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9444]



-----------------------------------------------------------------------

DEPARTMENT OF EDUCATION
[CFDA No.: 84.162A]


Emergency Immigrant Education Program; Notice Inviting 
Applications for New Awards for Fiscal Year (FY) 1995

    Purpose of Program: This program provides grants to State 
educational agencies (SEAs) to assist local educational agencies that 
experience large increases in their student population due to 
immigration. These grants are to be used to provide high-quality 
instruction to immigrant children and youth and to help such children 
and youth transition into American society and meet the same 
challenging State performance standards expected of all children and 
youth.
    Eligible Applicants: State educational agencies.
    Deadline for Transmittal of Applications: May 30, 1995.
    Deadline for Intergovernmental Review: July 29, 1995.
    Applications Available:  April 21, 1995.
    Available Funds: $50 million.
    Project Period: Up to 16 months.
    Applicable Regulations: The Education Department General 
Administrative Regulations (EDGAR) in 34 CFR parts 76, 77, 79, 80, 81, 
82, 85, and 86.
    Programmatic Information: An SEA may apply for a grant if it meets 
the eligibility requirements specified in section 7304 of the 
Elementary and Secondary Education Act of 1965, as amended by the 
Improving America's School's Act of 1994 (Pub. L. 103-82, enacted 
October 20, 1994). An eligible SEA must provide a count, taken during 
April 1995, of the number of immigrant children and youth enrolled in 
public and nonpublic schools in accordance with the requirements 
specified in section 7304 of the Act. Under section 7501 (7) of the 
Act, the term ``immigrant children and youth'' means individuals who 
are aged 3 through 21, were not born in any State, and have not been 
attending one or more schools in any one or more States for more than 
three full academic years.
    For Applications or Information Contact: Ms. Harpreet K. Sandhu or 
Ms. Soccoro Lara, U.S. Department of Education, 600 Independence 
Avenue, SW., Room 5086, Switzer Building, Washington, DC 20202-6510. 
Telephone: Harpreet Sandhu (202) 205-9808 or Socorro Lara (202) 205-
5711. Individuals who use a telecommunications device for the deaf 
(TDD) may call the Federal Information Relay Service (FIRS) at 1-800-
877-8339 between 8 a.m. and 8 p.m., Eastern time, Monday through 
Friday.

    Program Authority: 20 U.S.C. 7541-7549.

    Dated: April 11, 1995.
Eugene E. Garcia,
Director, Office of Bilingual Education and Minority Languages Affairs.
[FR Doc. 95-9444 Filed 4-17-95; 8:45 am]
BILLING CODE 4000-01-P
Exhibit 32.2

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of Bioforce Nanosciences Holdings, Inc., a Nevada corporation (the "Company"), do hereby certify, to the best of their knowledge, that:



1.     The Quarterly Report on Form 10-Q for the period ending March 31, 2018 (the "Report") of the Company complies in all material respects with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



2.     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                    |                                                                
|------------------- | ---------------------------------------------------------------
|                    |                                                                
|Dated: May 11, 2018 | /s/Richard Kaiser
Richard Kaiser
Acting Chief Financial Officer
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. ss.1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Solely for the
purposes of complying with, and the extent required by 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned certifies, in his capacity as the Chief Financial Officer of BlastGard® International, Inc., that, to his knowledge, the Annual
Report of the company on Form 10-KSB for the period ended December 31, 2005, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the report fairly
presents, in all material respects, the companys financial condition and results of operations.

March 29, 2006



|                                          
|------------------------------------------
|/s/ Michael J. Gordon                     
|Michael J. Gordon, Chief Financial Officer



7
##### 



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADDED BY
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and2.
    
    The information contained in this Report fairly
presents, in all material respects, the consolidated
financial condition and results of the Company as of
and for the period covered by this Report.
 By:
    
    /s/ William J. McGurkWilliam J. McGurkPresident and Chief ExecutiveOfficerMay 15, 2006By:
    
    /s/ Gregory A. WhiteGregory A. WhiteSVP, Chief Financial Officer andTreasurerMay 15, 2006
   37
[Federal Register Volume 61, Number 81 (Thursday, April 25, 1996)]
[Notices]
[Page 18410]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10265]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--International Pharmaceutical Aerosol Consortium 
for Toxicology Testing of HFA-134a (IPACT-I)

    Notice is hereby given that, on May 25, 1995, pursuant to Section 
6(a) of the National Cooperative Research and Production Act of 1993, 
15 U.S.C. Sec. 4301 et seq. (``the Act''), The International 
Pharmaceutical Aerosol Consortium for Toxicology Testing of HFA-134a 
(``IPACT-I'') has filed written notifications simultaneously with the 
Attorney General and the Federal Trade Commission disclosing (1) a 
Restated IPACT-I Formation Agreement and (2) the addition of a new 
member. The notifications were filed for the purpose of extending the 
Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Specifically, the 
following has become a new member to the IPACT-I: TAP Holdings, Inc., 
Deerfield, IL. The Restated Formation Agreement became effective on May 
8, 1995, and supersedes the prior agreement under which the Consortium 
operated. The only significant change created by the new Agreement is 
that membership in IPACT-I is now open to any party that: (1) has a 
commercial interest in pharmaceutical aerosols, and (2) undertakes to 
pay its share of IPACT-I costs.
    No other changes have been made in either the membership or planned 
activity of IPACT-I. Membership in this group research project remains 
open, and IPACT-I intends to file additional written notification 
disclosing all changes in membership.
    On August 7, 1990, IPACT-I filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
September 6, 1990 (55 Fed. Reg. 36710).
    The last notification was filed with the Department on January 14, 
1993. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on April 27, 1993 (58 FR 25657).
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 96-10265 Filed 4-24-96; 8:45 am]
BILLING CODE 4410-01-M
Order entered October 1, 2013

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-13-00524-CV

BRIAN CAYCE BERTRAND, Appellant

V.

JOHN DAVID BERTRAND, ET AL., Appellees

On Appeal from the 191st Judicial District Court

Dallas County, Texas

Trial Court Cause No. 11-15646

ORDER

We GRANT appellant’s September 11, 2013 second motion to file an amended brief to 

the extent that appellant shall file his amended brief on or before OCTOBER 7, 2013.

/s/ DAVID LEWIS 

JUSTICE
#### Shelley Dorcel MILLS, Appellant, v. Eric Scott MILLS, Respondent.

No. 66036.

Missouri Court of Appeals, Eastern District, Division One.

May 9, 1995.

Melvin L. Raymond, St. Louis, for appellant.

Richard J. Eisen, St. Louis, for respondent.

Before REINHARD, P.J., and GARY M. GAERTNER and CRAHAN, JJ.

*ORDER*

Appellant, Shelly Dorcel Mills, appeals from a dissolution decree entered in the Circuit Court of the County of St. Louis. We affirm.

We have reviewed the briefs of the parties and the legal file and find the judgment of the circuit court is supported by substantial evidence and is not against the weight of the evidence. As an extended opinion would serve no jurisprudential purpose, we affirm the circuit court’s judgment pursuant to Rule 84.16(b). A memorandum solely for the use of the parties involved has been provided explaining the reasons for our decision.
EX-10.1






Digene Corporation Non-Employee Director Compensation Policy




Under the current Non-Employee Director Compensation Policy of Digene Corporation (“Digene”),
each non-employee director is entitled to receive:




	 	•	 	an annual retainer fee of $25,000 for each non-employee director;






	 	•	 	an additional annual retainer of $50,000 for any non-executive Chairman of the
Board, $10,000 for the Audit Committee Chair, $5,000 for the other Audit Committee
members, $5,000 for the Compensation Committee Chair and $5,000 for the Nominating and
Corporate Governance Committee Chair (includes service as Lead Director);






	 	•	 	a fee of $1,500 for each Board meeting attended in person, and $750 for each
in-person Board meeting attended by conference telephone;






	 	•	 	a fee of $750 for each telephonic Board meeting lasting longer than thirty minutes;






	 	•	 	a fee of $1,000 for each Audit, Compensation or Nominating and Corporate Governance
Committee meeting attended in person other than committee meetings held on the same day
as in-person Board meetings;






	 	•	 	a fee of $500 for each telephonic Audit, Compensation or Nominating and Corporate
Governance Committee meeting lasting longer than thirty minutes;






	 	•	 	a fee of $500 for each Compliance Committee meeting attended in person other than
committee meetings held on the same day as in-person Board meetings;






	 	•	 	a fee of $250 for each telephonic Compliance Committee meeting lasting longer than
thirty minutes;






	 	•	 	upon first joining the Board, a grant of stock options to purchase 10,000 shares of
our common stock, which will become exercisable as to 33%, 33% and 34% of the
underlying shares on the first, second and third anniversaries of the date of grant and
have a term of seven years;






	 	•	 	upon first joining the Board, an award of restricted stock units with a fair market
value of $90,000 on the date of such award, which will vest as to 33%, 33% and 34% on
each of the first, second and third anniversaries of the date of grant;






	 	•	 	an annual grant, to each non-employee director who will continue to serve as a
director after the annual meeting of our stockholders, of immediately exercisable stock
options to purchase 5,000 shares of our common stock;






	 	•	 	an annual award, to each non-employee director who will continue to serve as a
director after the annual meeting of our stockholders, of restricted stock units with a
fair market value of $45,000 on the date of such award, which will vest on the earlier
of the date of the next annual meeting of our stockholders or the first anniversary of
the award date; and






	 	•	 	reimbursement for all reasonable travel expenses incurred in connection with Board
of Directors’ meetings and meetings of committees of the Board of Directors.
#### Percy DOWNER, Movant/Appellant, v. STATE of Missouri, Respondent.

No. 65330.

Missouri Court of Appeals, Eastern District, Division One.

Aug. 16, 1994.

Motion for Rehearing and/or Transfer to Supreme Court Denied Sept. 20, 1994.

Application to Transfer Denied Oct. 25, 1994.

*326David C. Hemingway, Asst. Public Defender, St. Louis, for appellant.

Jeremiah W. (Jay) Nixon, Atty. Gen., John R. Munich, Asst. Atty. Gen., Jefferson City, for respondent.

Before REINHARD, P.J., and CRIST and CRAHAN, J.J.

*ORDER*

PER CURIAM.

Movant appeals from the denial, ■ without an evidentiary hearing, of his Rule 24.035 motion for post-conviction relief. We affirm. The findings and conclusions of the motion court are not clearly erroneous, and an extended opinion would have no precedential value. The parties have been furnished with a memorandum for their information only, setting forth the reasons for this order affirming the judgment pursuant to Rule 84.-16(b).
[Federal Register Volume 61, Number 85 (Wednesday, May 1, 1996)]
[Notices]
[Page 19325]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10803]



-----------------------------------------------------------------------


NATIONAL SCIENCE FOUNDATION

Special Emphasis Panel in Human Resource Development; Notice of 
Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation announces the 
following meeting.

    Name and Committee Code: Special Emphasis Panel in Human 
Resource Development (#1199).
    Date and Time: May 15, 1996, 8:00 a.m. to 3:00 p.m.
    Place: National Science Foundation, 4201 Wilson Boulevard, Room 
380, Arlington, VA 22230.
    Time of Meeting: Closed.
    Contact Person: Dr. William McHenry, Program Director, Human 
Resource Development Division, Room 815, National Science 
Foundation, 4201 Wilson Boulevard, Arlington, VA 22230 Telephone: 
(703) 306-1634.
    Purpose of Meeting: To provide advice and recommendations 
concerning proposals submitted to NSF for Continuation of financial 
support.
    Agenda: Review for the Alliances for Minority Participation 
Reverse Site Visit.
    Reason for Closing: The proposals being reviewed include 
information of a proprietary or confidential nature, including 
technical information; financial data, such as salaries; and 
personal information concerning individuals associated with the 
proposals. These matters are exempt under 5 U.S.C. 552b(c), (4) and 
(6) of the Government in the Sunshine Act.

    Dated: April 26, 1996.
M. Rebecca Winkler,
Committee Management Officer.
[FR Doc. 96-10803 Filed 4-30-96; 8:45 am]
BILLING CODE 7555-01-M
Exhibit 32.1

CERTIFICATION

In connection with the Quarterly Report on Form 10-Q of Accentia Biopharmaceuticals, Inc. (the
Company) for the three months ended December 31, 2006, as filed with the Securities and Exchange Commission on the date hereof (the Form 10-Q), I, Francis E. ODonnell, Jr., Chairman of the Board and Chief Executive
Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended: and

(2)
The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 14, 2007



|                                                        
|--------------------------------------------------------
|/s/ Francis E. ODonnell, Jr.                           
|Francis E. ODonnell, Jr., M.D.                         
|Chief Executive Officer; Chairman of the Board; Director

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and
Exchange Commission, and is not to be incorporated by reference into any filing of Accentia Biopharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the
date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.
**EXHIBIT 32.1**

 

**CAMBER ENERGY, INC.****Certification Pursuant to18 U.S.C. Section 1350,as Adopted Pursuant toSection 906 of the Sarbanes-Oxley Act of 2002**

 

In connection with the Quarterly Report of Camber Energy, Inc. (the Company) on Form 10-Q/A for the quarterly period ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, James Doris, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

|   | (1)    | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                |
|--------|--------|------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |
|   | (2)    | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |

 

|                     | */s/**James Doris*     |   |
|--------------------------|-----------------------------|--------|
| Date: May 17, 2022  | James Doris                 |   |
|                     | Principal Executive Officer |   |
IN THE SUPREME COURT OF TEXAS

-- -- -- --

denied

NO. 14-0183

ST. LUKE'S SUGAR LAND

PARTNERSHIP, L.L.P. AND ST.

LUKE'S COMMUNITY

DEVELOPMENT CORPORATIONSUGAR LAND

v.

SHATISH PATEL, M.D.,

HEMALATHA VIJAYAN, M.D.,

SUBODH SONWALKAR, M.D. AND

WALLEY OLADUT, M.D.

§

§

§

§

§

§

Harris County,

1st District.

October 24, 2014

Petitioners' petition for review, filed herein in the above numbered and styled case,

having been duly considered, is ordered, and hereby is, denied.

January 9, 2015

Petitioner's motion for rehearing of petition for review, filed herein in the above

numbered and styled case, having been duly considered, is ordered, and hereby is, denied.



I, BLAKE A. HAWTHORNE, Clerk of the Supreme Court of Texas, do hereby certify

that the above and attached is a true and correct copy of the orders of the Supreme Court of

Texas in the case numbered and styled as above, as the same appear of record in the minutes of

said Court under the date shown.

It is further ordered that petitioner, ST. LUKE'S SUGAR LAND PARTNERSHIP, L.L.P.

AND ST. LUKE'S COMMUNITY DEVELOPMENT CORPORATION-SUGAR LAND, pay all

costs incurred on this petition.

FILE COPY
WITNESS my hand and seal of the Supreme Court of Texas, at the City of Austin, this

the 22nd day of January, 2015.

Blake A. Hawthorne, Clerk

By Monica Zamarripa, Deputy Clerk

FILE COPY
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of BioForce Nanosciences  Holdings,
Inc.  (the  "Company") on Form 10-QSB/A for the period ending March 31, 2006, as
filed with the  Securities  and  Exchange  Commission  on the date  hereof  (the
"Report"), I, Eric Henderson,  Chief Executive Officer of the Company,  certify,
pursuant  to 18  U.S.C.  Sec.  1350,  as  adopted  pursuant  to Sec.  906 of the
Sarbanes-Oxley Act of 2002, that:

     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
     15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
     material respects,  the financial condition and result of operations of the
     Company.


/s/   ERIC HENDERSON
------------------------------
Eric Henderson
Chief Executive Officer
August 7, 2006



     A signed  original of this  written  statement  required by Section 906, or
     other document  authenticating,  acknowledging,  or otherwise  adopting the
     signature that appears in typed form within the electronic  version of this
     written  statement has been provided to the Company and will be retained by
     the Company and furnished to the Securities and Exchange  Commission or its
     staff upon  request.  The foregoing  certifications  are  accompanying  the
     Company's   Form   10-QSB/A   solely   pursuant   to  section  906  of  the
     Sarbanes-Oxley  Act of  2002  (subsections  (a) and  (b) of  section  1350,
     chapter 63 of title 18,  United States Code) and is not being filed as part
     of the Form 10-QSB/A or as a separate disclosure document.